Biomerica Unit Is Issued a Patent for Allergy Treatment Method
- Share via
NEWPORT BEACH — Biomerica Inc. said its Allergy Immuno Technologies Inc. unit has been issued a patent for a new method of treating allergies.
In a press release, the company said the latest patent covers an invention under which an allergen--the material to which a patient is allergic--is combined with something called a biological response modifier. The patent covers a class of such modifiers.
Biomerica said it plans to enter a “collaborative arrangement” with a drug company to use the invention. In the meantime, the company said, it intends to raise funds necessary for its allergy unit to begin marketing the new treatments.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
